Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 146.07 | 106.07 | 127.76 | 104.13 |
Depreciation/ Depletion | 26.38 | 18.67 | 17.33 | 17.23 |
Non- Cash Items | 11.81 | 39.24 | -49.04 | 29.06 |
Changesin Working Capital | -31.81 | -129.67 | 39.43 | -86.45 |
Cashfrom Operating Activities | 152.45 | 34.31 | 135.48 | 63.97 |
Capital Expenditures | -28.33 | -93.80 | -74.00 | -9.12 |
Other Investing Cash Flow Items Total | -104.49 | 86.05 | -18.97 | -37.87 |
Cashfrom Investing Activities | -132.82 | -7.75 | -92.98 | -46.99 |
Financing Cash Flow Items | -6.06 | -6.30 | -2.96 | -6.32 |
Total Cash Dividends Paid | -5.39 | -5.44 | -5.33 | -5.55 |
Issuance( Retirement)of Stock Net | 2.31 | 2.04 | 2.28 | - |
Issuance( Retirement)of Debt Net | -11.75 | -15.25 | -17.73 | -8.93 |
Cashfrom Financing Activities | -20.89 | -24.94 | -23.73 | -20.80 |
Foreign Exchange Effects | -0.15 | 1.40 | -9.92 | 1.61 |
Net Changein Cash | -1.42 | 3.02 | 8.85 | -2.21 |
Cash Interest Paid | 6.10 | 6.30 | 2.96 | 6.32 |
Cash Taxes Paid | 34.85 | 44.56 | 33.94 | 28.56 |
Bliss Gvs Pharma Dividend Bliss Gvs Pharma Bonus Bliss Gvs Pharma News Bliss Gvs Pharma AGM Bliss Gvs Pharma Rights Bliss Gvs Pharma Splits Bliss Gvs Pharma Board Meetings Bliss Gvs Pharma Key Metrics Bliss Gvs Pharma Shareholdings Bliss Gvs Pharma Profit Loss Bliss Gvs Pharma Balance Sheet Bliss Gvs Pharma Q1 Results Bliss Gvs Pharma Q2 Results Bliss Gvs Pharma Q3 Results Bliss Gvs Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks